Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you GSK (GlaxoSmithKline)
Global positioning
5
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Top therapy classes by spending global market 2027 forecast
- Premium Statistic Leading European pharmaceutical & biotechnology companies by market cap 2023
- Basic Statistic Pharma company ranking based on access to medicine in developing countries 2022
- Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
Key facts
4
Business segments
4
Competitors
5
Research and development
4
- Premium Statistic GSK: expenditure on research and development 2006-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2024
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
Further related statistics
10
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Further Content: You might find this interesting as well
Statistics
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Gilead Sciences. (February 23, 2024). Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 16, 2024, from https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/
Gilead Sciences. "Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars)." Chart. February 23, 2024. Statista. Accessed June 16, 2024. https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/
Gilead Sciences. (2024). Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 16, 2024. https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/
Gilead Sciences. "Gilead Sciences' Revenue from 2006 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 23 Feb 2024, https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/
Gilead Sciences, Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/ (last visited June 16, 2024)
Gilead Sciences' revenue from 2006 to 2023 (in million U.S. dollars) [Graph], Gilead Sciences, February 23, 2024. [Online]. Available: https://www.statista.com/statistics/274508/revenue-and-net-income-of-gilead-sciences/